0001171843-13-003189.txt : 20130805 0001171843-13-003189.hdr.sgml : 20130805 20130805170526 ACCESSION NUMBER: 0001171843-13-003189 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130801 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20130805 DATE AS OF CHANGE: 20130805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 131010907 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 8-K 1 f8k_080513.htm FORM 8-K f8k_080513.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

August 1, 2013
Date of report (Date of earliest event reported)
 
Amyris, Inc.
(Exact name of Registrant as specified in its charter)
 
Delaware
001-34885
55-0856151
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. Employer Identification
No.)
 
 
 
5885 Hollis Street, Suite 100, Emeryville, CA
94608  
  (Address of principal executive offices) (Zip Code)  
 
 
(510) 450-0761
 
 
(Registrant’s telephone number, including area code)
 
 
     
 
(Former name or former address, if changed since last report.)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
 
  [    ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [    ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [    ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [    ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.

On August 1, 2013, the Board of Directors (the “Board”) of Amyris, Inc. (the “Company”) appointed Karen Weaver, Vice President and Corporate Controller, as the principal accounting officer of the Company, effective immediately.  Steven R. Mills, the Company’s Chief Financial Officer and previous principal accounting officer, will remain the principal financial officer of the Company.

Ms. Weaver, age 52, has served as the Company’s Vice President and Corporate Controller since October 2012.  From May 2011 to September 2012, Ms. Weaver served as the Vice President, Accounting and Assistant Controller at Amyris. Prior to joining the Company, Ms. Weaver served as the Vice President and Corporate Controller at Sonic Solutions, a publicly-traded digital media software and entertainment solutions provider from September 2009 until its acquisition by Rovi Corporation in February 2011 and subsequently to April 2011 to assist in integration activities. From March 2006 to August 2009, Ms. Weaver held various senior accounting roles at Sonic Solutions.

The Company has entered or will enter into the form of indemnification agreement with Ms. Weaver that it has entered into with its other officers and that is filed as Exhibit 10.01 to the Company’s registration statement on Form S-1 (File No. 333-166135).  The indemnification agreement and the Company’s restated certificate of incorporation and restated bylaws require the Company to indemnify its directors and executive officers to the fullest extent permitted by Delaware law.
 
 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

   
AMYRIS, INC.
 
       
Date:  August 5, 2013
By:
/s/ Steven R. Mills
 
   
Steven R. Mills
 
   
Chief Financial Officer